Comportamiento epidemiológico de las dislipidemias en pacientes del Instituto de Investigaciones Endocrino-Metabólicas Dr. Félix Gómez, Venezuela
| dc.contributor.author | Gotera, Jennifer Lucila | |
| dc.contributor.author | Valero, Nereida Josefina | |
| dc.contributor.author | Ávila, Ayari Guadalupe | |
| dc.contributor.author | Mosquera, Jesús Alberto | |
| dc.contributor.author | Linares, Johan Carlos | |
| dc.contributor.author | Amell de Diaz, Anilsa | |
| dc.contributor.author | Chacín-González, Maricarmen | |
| dc.contributor.author | Bermúdez, Valmore | |
| dc.date.accessioned | 2020-01-30T15:11:50Z | |
| dc.date.available | 2020-01-30T15:11:50Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Introducción: Las dislipidemias constituyen un factor de riesgo cardiovascular esencial en el desarrollo de la aterosclerosis. Objetivo: Estudiar las alteraciones lipídicas en individuos adultos de un centro de atención endocrino-metabólico. Métodos: Estudio descriptivo, no experimental, y transversal. Se evaluaron 214 individuos mayores de 18 años, a los cuales se les determinó niveles séricos de colesterol total, triacilglicéridos, y HDL-c por métodos convencionales. El LDL-c y las VLDL-c se calcularon por las ecuaciones de Friedewald. Si los TAG fueron mayores a 400 mg/dL la concentración de LDL-c se determinó de forma directa. Las variables se expresaron en frecuencias absolutas y relativas, Media ± Desviación estándar, y como prueba de hipótesis la prueba t de Student según el caso, aceptándose un valor de p<0,05 como estadísticamente significativo. Resultados: El 78% de la muestra correspondió al sexo femenino. La media aritmética de la edad fue de 50,22± 16,4 años. La prevalencia general de dislipidemias fue del 86,9% (n=214), siendo del 91,6% en las mujeres y del 70,2% en los hombres; solo el 13,0% (n=28) de los individuos fueron eulipémicos. La frecuencia de las dislipidemias observadas fue: LDL-c elevado aislado 24,7%, Hipertriacilgliceridemia aislada 18,2%, Hipertriacilgliceridemia con HDL-c Bajas 13,5%, Dislipidemia Mixta 13,5%. Conclusión: La alta prevalencia de dislipidemias en los pacientes estudiados es característica de un centro para la atención de estas patologías, observándose una prevalencia elevada de HDL-c bajas e Hipertriacilgliceridemia. Estos resultados justifican la determinación de lípidos séricos para identificar de manera temprana y oportuna este conjunto de alteraciones con la finalidad de prevenir potenciales complicaciones cardiometabólicas. | spa |
| dc.description.abstract | Introduction: Dyslipidemias constitute an essential cardiovascular risk factor in the development of atherosclerosis. Objective: To study the lipid alterations in adult individuals of a center of endocrine-metabolic attention. Methods: Descriptive, non-experimental, and cross-sectional study. We evaluated 214 individuals older than 18 years, who were determined serum levels of total cholesterol, triacylglycerides, and HDL-c by conventional methods. The LDL-c and the VLDL-c were calculated by the Friedewald equations. If the TAG was greater than 400 mg/dL, the LDL-c concentration was determined directly. The variables were expressed in absolute and relative frequencies, mean±standard deviation, and as a hypothesis test the Student t test according to the case, accepting a p<0.05 as statistically significant. Results: 78% of the sample corresponded to the female sex. The arithmetic mean of age was 50.22 ± 16.4 years. The general prevalence of dyslipidemias was 86.9% (n=214), being 91.6% in women and 70.2% in men; only 13.0% (n=28) of the individuals were eulipemic. The frequency of the dyslipidemias observed was: isolated high LDL-c 24.7%, isolated hyperthercylglyceridemia 18.2%, hyperthercylglyceridemia with low HDL-c 13.5%, mixed dyslipidemia 13.5%. Conclusion: The high prevalence of dyslipidemias in the studied patients is characteristic of a center for the attention of these pathologies, being observed a high prevalence of low HDL-c and Hypertriacilgliceridemia. These results justify the determination of serum lipids to identify early and timely this set of alterations before potential cardiometabolic complications. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.issn | 26107988 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/4607 | |
| dc.language.iso | spa | eng |
| dc.publisher | Cooperativa servicios y suministros 212518 RS | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Revista Latinoamericana de Hipertensión | spa |
| dc.source | Vol. 14, No. 5 (2019) | spa |
| dc.source.uri | http://www.revhipertension.com/rlh_5_2019/14_comportamiento_epidemiologico.pdf | |
| dc.subject | Dislipidemia | spa |
| dc.subject | Lipoproteínas | spa |
| dc.subject | Triacilglicéridos | spa |
| dc.subject | Colesterol | spa |
| dc.subject | Enfermedad cardiovascular | spa |
| dc.subject | Dyslipidemia | eng |
| dc.subject | Cardiovascular disease | eng |
| dc.title | Comportamiento epidemiológico de las dislipidemias en pacientes del Instituto de Investigaciones Endocrino-Metabólicas Dr. Félix Gómez, Venezuela | spa |
| dc.title.alternative | Dyslipidemia epidemiological behaviour in patients from the Endocrine and Metabolic diseases research Institute Dr. Félix Gómez at Universidad del Zulia, Venezuela | eng |
| dc.type | article | eng |
| dc.type.driver | article | eng |
| dcterms.references | Varona P, Bonet M, García R, Chang M, Ramón R. Implementation of Chronic Disease Risk Factor Surveillance in 12 Cuban Municipalities. MEDICC Rev. 2014; 16 (1): 43-7. | eng |
| dcterms.references | Rodríguez Domínguez L, Fernández-Britto J, Díaz Sánchez M, Ruiz Álvarez V, Hernández Hernández H, Herrera Gómez V, et al. Sobrepeso y dislipidemias en adolescentes. Rev Cubana Pediatr. 2014; 86:433-44. | spa |
| dcterms.references | Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela. Anuario de Mortalidad 2008. Caracas: MPPS de Venezuela; 2010. | spa |
| dcterms.references | Pramparo P, Boissonnet C, Schargrodsky H. Evaluación del riesgo cardiovascular en siete ciudades de Latinoamérica: las principales conclusiones del estudio CARMELA y de los subestudios. Rev Argent Cardiol. 2011; 79:377-382. | spa |
| dcterms.references | Ḉetin I, Yildirim B, Sahín S, Sahín I, Etíkan I. Serum lipid and lipoprotein levels, dyslipidemia prevalence, and the factors that influence these parameters in a Turkish population living in the province of Tokat. Turk J Med Sci. 2010; 40:771-782. doi:10.3906/sag-0911-430. | eng |
| dcterms.references | Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelian dysfunction: a comprehensive appraisal. Cardiovasr Diabetol 2006; 4: 1-18. doi: 10.1186/1475-2840-5-4. | eng |
| dcterms.references | Acevedo M, Krämer V, Tagle R, Corbalán R, Arnaíz P, Berríos X, Navarrete C. Relación colesterol total a HDL y colesterol no HDL: los mejores indicadores lipídicos de aumento de grosor de la íntima media carotidea. Rev Med Chile 2012; 140: 969-976. doi.org/10.4067/ S0034-98872012000800001. | spa |
| dcterms.references | Linares S, Bermúdez V, Rojas J, González R, Torres W, Mejías J, et al. Prevalencia de dislipidemias y factores psicobiológicos asociados en individuos adultos del municipio Maracaibo, Venezuela. Síndrome Cardiometabólico. 2013; 3: 63-75. | spa |
| dcterms.references | Grundy SM, Cleeman JI, Merz NB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110:227-239. | eng |
| dcterms.references | Friedewald WT, Levi, RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502. | eng |
| dcterms.references | Virani SS, Woodard LD, Landrum CR, Pietz K, Wang D, Ballantyne CM, et. al. Institutional, provider, and patient correlates of low- densitylipoprotein and non-high- densitylipoproteincholesterolgoalattainmentaccordingtotheAdultTreatment Panel III guidelines. Am Heart J. 2011; 161:1140–1146. | eng |
| dcterms.references | Kannel WB, Castelli WP, Gordon T. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Int Med 1971; 74:1-12. | eng |
| dcterms.references | Chobaniam AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289:2560-2572. | eng |
| dcterms.references | Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein colesterol levels. The Framingham Study. JAMA. 1986; 256: 2835–2838. | eng |
| dcterms.references | Gerd Assmann, Paul Cullen, Helmut Schulte. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10- Year Follow-Up of nary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation. 2002; 105: 310-315. | eng |
| dcterms.references | V Manninen, M. O. Elo, M. H. Frick, K. Haapa, O. P. Heinonen, P, Heinsalmi, P. Helo, et al. Et Lipid alterations and decline in the incidence of coronary heart diseas in the Helsinki Heart Study. JAMA, 1988; 260 (5):641-51. | eng |
| dcterms.references | Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977; 1: 965–968. | eng |
| dcterms.references | Gordon DJ, Probstfield JL, Garrisson RJ, Neaton JD, Castelli WP, Knoke JD et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79: 8-15 | eng |
| dcterms.references | Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006; 113:647-656. | eng |
| dcterms.references | Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012; 308:1175-1184. doi: 10.1001/jama.2012.14517. | eng |
| dcterms.references | Munguía-Miranda C, Sánchez-Barrera RG, Hernández Saavedra D, Cruz-López M. Prevalencia de dislipidemias en una población de sujetos en apariencia sanos y su relación con la resistencia a la insulina. Salud Publica Mex. 2008; 50:375-382. | spa |
| dcterms.references | Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998; 15:539-553. | eng |
| dcterms.references | Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, et al. Defective regulation of triglyceride metabolism by insulin in the liver NIDDM. Diabetologia. 1997; 40:454-462. | eng |
| dcterms.references | Núñez M, Rojas J, Torres W, González R, Mejías J, Olivar L. Características sociodemográficas asociadas a dislipidemia en el estudio de prevalencia de síndrome metabólico de Maracaibo, Venezuela. Revista Latinoamericana de Hipertensión. 2013; 8. Recuperado de: https:// www.researchgate.net/publication/293556496. | spa |
| dcterms.references | Luti, Y, Bermúdez, V, Mengual, E, Cano, C, Sánchez, D, Scott, G, Velasco,M. Prevalencia de las diferentes alteraciones del perfil lipídico en la consulta de Factores de Riesgo Cardiovascular del Centro de Investigaciones Endocrino-Metabólicas “Dr. Félix Gómez” en el período de enero del 2006 a enero de 2007. Revista Latinoamericana de Hipertensión [Internet]. 2008; 3:174-181. Recuperado de: http://www.redalyc. org/articulo.oa?id=170216929002. | spa |
| dcterms.references | Ochoa S, Millán R, Rojas Z, Morillo J, Añez R, Rojas J, Valmore B. Variables antropométricas como predictores de dislipidemias en sujetos adultos del municipio San Cristóbal-Venezuela. Síndrome Cardiometabólico. 2017; VII. Nº 1: 1-13. | spa |
| dcterms.references | Aguilar C, Olaiz G, Valles V, Ríos J, Gómez F, Rull J, Rojas R, Franco A, et al. High prevalence of low HDL cholesterol concentrations and mixed Hyperlipidemia in a Mexican nationwide survey. J. Lipid Res. 2001; 42: 1298-130. | eng |
| dcterms.references | Forti N & Diament J. High-Density Lipoproteins: Metabolic, Clinical, Epidemiological and Therapeutic Intervention Aspects. An Update for Clinicians. Arq Bras Cardiol 2006; 87: 614-622. doi:10.1590/S0066-782X2006001800019 | eng |
| dcterms.references | Nichaman MZ, Garcia G. Obesity in Hispanic Americans. Diabetes Care. 1991. 14: 691–694. doi: 10.2337/diacare.14.7.691 | eng |
| dcterms.references | González C, Stern MP, González E, Rivera D, Simón J, Islas S, Haffner S. The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutr. Rev. 1999; 57: S71–S76. doi: 10.1111/j.1753-4887.1999.tb01792.x | eng |
| dcterms.references | Brewer HB Jr. Increasing HDL cholesterol levels. N Engl J. Med. 2004; 350:1491-1494. | eng |
| dcterms.references | Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA; Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein colesterol: The Nacional Herat, Lung, and Blood Institute Family Herat Study. Am Heart J. 2004; 147: 529-535 | eng |
| dcterms.references | Souki A, Arias N, Zambrano N, Falque L, Quintero J, García D, et al. Comportamiento del perfil lipídico en una muestra de población adulta de la Ciudad de Maracaibo. AVFT 2003; 22: 35-39 | spa |
| dcterms.references | Carrasco A, Ziegler E, Carpio, Montes de Oca I. Frecuencia de dislipidemia en una población de adultos jóvenes. Med Interna 2005; 21:238-251. | spa |
| oaire.version | info:eu-repo/semantics/publishedVersion | spa |